Recent patents on treatment of severe acute respiratory syndrome (SARS).

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Recent Patents on Anti-Infective Drug Discovery

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/157489107779561698PMID 18221160
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors.

  2005cited by this paper
• Obstacles and advances in SARS vaccine development

  2005cited by this paper
• Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque

  2005cited by this paper
• Inhibition of Replication and Infection of Severe Acute Respiratory Syndrome-Associated Coronavirus with Plasmid-Mediated Interference RNA

  2005cited by this paper
• Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease.

  2005influential reference
• Potent and specific inhibition of SARS-CoV antigen expression by RNA interference.

  2005cited by this paper
• Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine.

  2005cited by this paper
• Current Status of Anti-SARS Agents

  2005cited by this paper
• SARS vaccine development.

  2005cited by this paper
• Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic α,β-unsaturated esters

  2005cited by this paper
• Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors

  2005cited by this paper
• A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods.

  2005cited by this paper
• Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice.

  2004cited by this paper
• Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase

  2004cited by this paper
• A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

  2004cited by this paper
• Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.

  2004cited by this paper
• Synthetic Peptide Studies on the Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Glycoprotein: Perspective for SARS Vaccine Development

  2004cited by this paper
• Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS

  2004cited by this paper
• Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.

  2004cited by this paper
• Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.

  2004cited by this paper
• Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro.

  2004cited by this paper
• Inhibition of Severe Acute Respiratory Syndrome Virus Replication by Small Interfering RNAs in Mammalian Cells

  2004cited by this paper
• Vaccines and sera through plant biotechnology☆

  2004cited by this paper
• Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus

  2004cited by this paper
• Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro.

  2004cited by this paper
• Immunization with Modified Vaccinia Virus Ankara-Based Recombinant Vaccine against Severe Acute Respiratory Syndrome Is Associated with Enhanced Hepatitis in Ferrets

  2004cited by this paper
• Small molecules targeting severe acute respiratory syndrome human coronavirus.

  2004cited by this paper
• Identification of severe acute respiratory syndrome in Canada.

  2003cited by this paper
• Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs

  2003cited by this paper
• Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

  2003cited by this paper
• Effects of a SARS-associated coronavirus vaccine in monkeys

  2003cited by this paper
• A novel coronavirus associated with severe acute respiratory syndrome.

  2003cited by this paper
• SARS — beginning to understand a new virus

  2003cited by this paper
• Mechanisms and enzymes involved in SARS coronavirus genome expression.

  2003cited by this paper
• Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

  2003cited by this paper
• Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS

  2003cited by this paper
• Genetic modification: The production of recombinant pharmaceutical proteins in plants

  2003cited by this paper
• The Genome Sequence of the SARS-Associated Coronavirus

  2003cited by this paper
• The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

  2003cited by this paper
• SARS coronavirus: a new challenge for prevention and therapy.

  2003cited by this paper
• Coronavirus as a possible cause of severe acute respiratory syndrome

  2003cited by this paper
• Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

  2003cited by this paper
• Viral Replicase Gene Products Suffice for Coronavirus Discontinuous Transcription

  2001cited by this paper
• Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants

  2001cited by this paper
• Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants.

  2000cited by this paper

• Physical interventions to interrupt or reduce the spread of respiratory viruses

  2023cites this paper
• Current Research Trends in Cytokine Storm: A Scientometric Study.

  2022cites this paper
• Physical interventions to interrupt or reduce the spread of respiratory viruses.

  2020cites this paper
• Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2

  2020influential citation
• Structural Insight Into the Viral 3C-Like Protease Inhibitors: Comparative SAR/QSAR Approaches

  2017influential citation
• Physical interventions to interrupt or reduce the spread of respiratory viruses.

  2011cites this paper
• Physical interventions to interrupt or reduce the spread of respiratory viruses.

  2010cites this paper
• Individual and common inhibitors of coronavirus and picornavirus main proteases

  2009cites this paper
• Therapies for coronaviruses. Part I of II – viral entry inhibitors

  2009cites this paper